335
Views
21
CrossRef citations to date
0
Altmetric
Report

The efficacy of fractional carbon dioxide (CO2) laser combined with terbinafine hydrochloride 1% cream for the treatment of onychomycosis

, , , , , , , & show all
Pages 353-359 | Received 14 Dec 2016, Accepted 13 May 2017, Published online: 10 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marwa Abdallah, Mustafa M. Abu-Ghali, Mohamed Taha El-Sayed & Marwa Y. Soltan. (2022) Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient’s satisfaction in toenail onychomycosis treatment: an intra-patient comparative single-center study. Journal of Dermatological Treatment 33:1, pages 542-549.
Read now

Articles from other publishers (20)

Alireza Firooz, Shayan Zamani, Aliasghar Ghadrei, Azin Ayatollahi, Pegah Tamimi, Ali Khamesipour, Mahmoodreza Jafari & Mahsa Fattahi. (2023) Evaluation of Efficacy and Safety of Topical Nanoliposomal Amphotericin B 0.4% Gel as a Potential Treatment for Onychomycosis: An Interventional Pilot Clinical Study. Dermatologic Therapy 2023, pages 1-9.
Crossref
Ghada A. Nasif, Aliaa A. Amin & Maha H. Ragaie. (2023) Q‐switched Nd: YAG laser versus itraconazole pulse therapy in treatment of onychomycosis: A clinical dermoscopic and mycologic study . Journal of Cosmetic Dermatology 22:6, pages 1757-1763.
Crossref
Eeshaan Ranjan, Sandeep Arora, Ajay Shanker Sharma, Neha Sharma & Rajeshwari Dabas. (2023) Single-Session Fractional CO2 Laser following Urea Occlusion in Management of Onychomycosis: A Pilot Study. Skin Appendage Disorders 9:4, pages 268-274.
Crossref
Jianfeng Zhang, Peng Lin, Junchen Li, Chenqi Guo, Jingbo Zhai & Yu Zhang. (2022) Efficacy of laser therapy combined with topical antifungal agents for onychomycosis: a systematic review and meta-analysis of randomised controlled trials. Lasers in Medical Science 37:6, pages 2557-2569.
Crossref
Vinzent Kevin Ortner, Nhi Nguyen, Jonathan R. Brewer, Vita Solovyeva, Merete Haedersdal & Peter Alshede Philipsen. (2022) Fractional CO 2 laser ablation leads to enhanced permeation of a fluorescent dye in healthy and mycotic nails—An imaging investigation of laser–tissue effects and their impact on ungual drug delivery . Lasers in Surgery and Medicine 54:6, pages 861-874.
Crossref
Amany NassarHadeel AtefFatma EldeebRania Alakad. (2022) Vergleich der fraktionierten laserunterstützten Medikamentengabe und der intraläsionalen Injektion von Triamcinolonacetonid bei Nagelpsoriasis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 788-797.
Crossref
Amany Nassar, Hadeel Atef, Fatma Eldeeb & Rania Alakad. (2022) Comparison of fractional laser‐assisted drug delivery and intralesional injection of triamcinolone acetonide in nail psoriasis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 788-796.
Crossref
Soo Kyung Lee, Ho Young Kim, Jae Ho Lee, Un Ha Lee & Myoung Shin Kim. (2022) Real‐world effectiveness of a fractional CO 2 laser with topical antifungal agents for the treatment of onychomycosis . Dermatologic Therapy.
Crossref
Eeshaan Ranjan, Sandeep Arora & Neha Sharma. (2022) Fractional CO 2 laser with topical 1% terbinafine cream versus oral itraconazole in the management of onychomycosis: A randomized controlled trial . Indian Journal of Dermatology, Venereology and Leprology 89, pages 47-53.
Crossref
Xiu-Hao Guan, Tian-Hua Xu, Xi Chen, Qi-Shuang Mu, Jing-Fei Suo, Rui-Xue Xu, John Chen, Ting Xiao, Gao Xing-Hua & Hong-Duo Chen. (2021) Fractionated carbon dioxide (CO2) laser treatment contributes to trans-nail penetration of rhodamine B and changes of cytokine microenvironment. Lasers in Medical Science 36:8, pages 1619-1623.
Crossref
Michelle J. Chang, Yuqing Qiu & Shari R. Lipner. (2021) Race reporting and representation in onychomycosis clinical trials: A systematic review. Mycoses 64:8, pages 954-966.
Crossref
Vinzent K. Ortner, Jon Holmes, Merete Haedersdal & Peter A. Philipsen. (2020) Morphometric Optical Imaging of Microporated Nail Tissue: An Investigation of Intermethod Agreement, Reliability, and Technical Limitations. Lasers in Surgery and Medicine 53:6, pages 838-848.
Crossref
J. F. J. Rovers, L.V. Wagter, E.G.E. Greijmans & H. J. Bovenschen. (2020) 1064-nm Nd:YAG laser treatment for onychomycosis: is it worthwhile?. Lasers in Medical Science 36:2, pages 463-467.
Crossref
Suraj Pawar & AshishR Deshmukh. (2021) To compare the efficacy of oral terbinafine alone against the combination of oral terbinafine and intense pulsed light (IPL) in difficult to treat tinea patients. MGM Journal of Medical Sciences 8:3, pages 253.
Crossref
Aditya K. Gupta, Maanasa Venkataraman & Emma M. Quinlan. 2021. Dermatophytes and Dermatophytoses. Dermatophytes and Dermatophytoses 433 471 .
Tro V. Chau, Long P. Mai, Hao T. Nguyen, Suong M. Nay, Huyen T.N. Nguyen & Thang T. Nguyen. (2020) Fractional Carbon-Dioxide Laser Plus Topical Clotrimazole versus Oral Itraconazole plus Topical Clotrimazole for Onychomycosis: A Randomized, Controlled Trial. The Open Dermatology Journal 14:1, pages 16-21.
Crossref
Sandeep Arora, Sandeep Lal, ManasaShettisara Janney, Eeshaan Ranjan, Navya Donaparthi & Rajeshwari Dabas. (2020) Fractional CO 2 laser in the management of onychomycosis . Journal of Marine Medical Society 22:1, pages 50.
Crossref
Amr Mohamed Zaki, Hamed Mohamed Abdo, Mohamed Anwer Ebadah & Shady Mahmoud Ibrahim. (2019) Fractional CO 2 laser plus topical antifungal versus fractional CO 2 laser versus topical antifungal in the treatment of onychomycosis . Dermatologic Therapy 33:1.
Crossref
Rania Ahmed El-Tatawy, Heba Ahmed Aliweh, Doaa Salah Hegab, Raghda Ahmed Zaki Talaat & Maii Atef Shams Eldeen. (2019) Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers in Medical Science 34:9, pages 1873-1880.
Crossref
Kelvin Yeung, Vinzent Kevin Ortner, Torben Martinussen, Uwe Paasch & Merete Haedersdal. (2019) Efficacy of laser treatment for onychomycotic nails: a systematic review and meta-analysis of prospective clinical trials. Lasers in Medical Science 34:8, pages 1513-1525.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.